Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

Creative Commons License

Koklu S., Gulsen M. T., Tuna Y., Koklu H., Yuksel O., Demir M., ...Daha Fazla

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.41, sa.3, ss.310-319, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/apt.13036
  • Dergi Adı: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.310-319
  • Gazi Üniversitesi Adresli: Evet

Özet

BackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection.